Key Leaders Depart as the FDA’s AI Fast Track Reaches a Governance Crossroads
Elsa is now connected to more than 40 application and review data sources and was originally intended to provide deeper support for drug reviews, trials, and inspections. Following a series of personnel changes, the pace of implementation, lines of responsibility, and transparency have become more urgent issues than functionality.